Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:7804763.
doi: 10.1155/2017/7804763. Epub 2017 Mar 2.

Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation

Ananília Medeiros Gomes da Silva  1 , Jéssica Nayara Góes de Araújo  1 , Renata Caroline Costa de Freitas  1 , Vivian Nogueira Silbiger  1
Affiliations
Review

Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation

Ananília Medeiros Gomes da Silva et al. Biomed Res Int. 2017.

Abstract

Atrial fibrillation (AF) is the most common supraventricular arrhythmia in the population. MicroRNAs (small endogenous noncoding RNAs) are attractive candidates as biomarkers for AF, especially considering that miRNAs are stable and are detected within easily accessible biofluids such as blood. In this review, we selected twelve studies (2012 to 2016) that were classified according to the sample type. We aimed to provide an overview of the role of circulating miRNAs in AF and to discuss the variability of the results, seeking to improve the perspective of the use of miRNAs as potential noninvasive biomarkers for this heart disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interests regarding the publication of this paper.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Soeki T., Matsuura T., Bando S., et al. Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. Journal of Cardiology. 2016;68(6):472–477. doi: 10.1016/j.jjcc.2015.12.007. - DOI - PubMed
    1. Zipes D. P., Camm A. J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. European Heart Journal. 2006;27(17):2099–2140. doi: 10.1093/eurheartj/ehl199. - DOI - PubMed
    1. Carlos A., Pimenta E., Drager L. F. Diretrizes Brasileiras de Hipertensão VI. Capítulo 7 Hipertensão Arterial Sistêmica Secundária. 2016;106:44–53.
    1. Weckbach L. T., Grabmaier U., Clauss S., Wakili R. MicroRNAs as a diagnostic tool for heart failure and atrial fibrillation. Current Opinion in Pharmacology. 2016;27:24–30. doi: 10.1016/j.coph.2016.01.001. - DOI - PubMed
    1. Bronze-Da-Rocha E. MicroRNAs expression profiles in cardiovascular diseases. BioMed Research International. 2014;2014:23. doi: 10.1155/2014/985408.985408 - DOI - PMC - PubMed